Durable, interpretable biosensing
Investor overview · IEUM Bionics
Investment activates a prepared technical foundation.
IEUM is already rich in ideas, invention groundwork and technical direction. Capital accelerates their path to protected, independently validated and scalable execution.
System definition and evidence architecture
Documented candidate portfolio
01
Invention & IP readiness
A double-digit invention portfolio. Built before funding.
IEUM Bionics has built a double-digit portfolio of documented invention candidates across its platform and application pipeline.
Priority candidates are already supported by structured invention dossiers, evidence architecture and comparison against public prior art—creating a strong internal foundation for staged IP protection.
Beyond the current portfolio, IEUM continues to expand a broader pipeline of technical concepts for future inclusion in its IP strategy.
With financing, IEUM will work with qualified patent counsel to convert this groundwork into a staged filing strategy, beginning with the highest-priority candidates.
02
Capital as accelerator
Turn prepared assets into protected, verified execution.
The current program plan connects financing directly to company formation, staged IP activity, independent technical validation and a focused development team in Germany.
Protect priority inventions
Advance the highest-value candidates through a staged filing strategy with qualified patent counsel.
Activate Product X
Translate the system definition and evidence architecture into focused development and testing.
Build independent evidence
Engage qualified partners to generate reviewable technical evidence against defined milestones.
Establish the company
Form the German operating base and assemble the core capabilities required for disciplined execution.
Current planning frame
A focused route from formation to evidence.
Current planning target
Company formation and evidence activation
Initial company-building focus
Structured system definition and evidence architecture
Planning figures guide IEUM's financing strategy and staged activation pathway.
03
Integrated capability
Disciplines designed to work as one.
- 01Living Interfaces
- 02Adaptive Biological Systems
- 03Embedded & Biosignal Systems
- 04Evidence, Quality & Regulatory Strategy
- 05IP Strategy & Independent Verification
Qualified diligence
Move from public overview to selected evidence.
Qualified investors and strategic partners can access selected proprietary technology, IP and evidence materials through a controlled diligence process supported by a fully executed mutual NDA.
Contact Junho JungFounder & CTO · IEUM Bionics · Germany